APA (7th ed.) Citation

YR, C., YJ, D., HB, W., DP, Y., LJ, Z., D, S., . . . XJ, C. (2016). Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes. Oncology letters, 12(5), 3312. https://doi.org/10.3892/ol.2016.5080

Chicago Style (17th ed.) Citation

YR, Cai, Dong YJ, Wu HB, Yu DP, Zhou LJ, Su D, Zhang L, and Chen XJ. "Expression Level of CRKL and AXL Combined with Exon 19 Deletion in EGFR and ALK Status Confer Differential Prognosis of Lung Adenocarcinoma Subtypes." Oncology Letters 12, no. 5 (2016): 3312. https://doi.org/10.3892/ol.2016.5080.

MLA (9th ed.) Citation

YR, Cai, et al. "Expression Level of CRKL and AXL Combined with Exon 19 Deletion in EGFR and ALK Status Confer Differential Prognosis of Lung Adenocarcinoma Subtypes." Oncology Letters, vol. 12, no. 5, 2016, p. 3312, https://doi.org/10.3892/ol.2016.5080.